Dupont Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Dupont Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,442	Closed	-$502K	–	1858
2021 Q1	$502K	Buy	1,442 +53	+4%	+$17.6K	0.01%	913
2020 Q4	$359K	Sell	1,389 -2,734	-66%	-$753K	0.01%	977
2020 Q3	$1.18M	Sell	4,123 -869	-17%	-$204K	0.03%	450
2020 Q2	$940K	Buy	4,992 +734	+17%	+$119K	0.02%	539
2020 Q1	$524K	Buy	4,258 +584	+16%	+$91.3K	0.01%	648
2019 Q4	$609K	Hold	3,674	–	–	0.01%	747
2019 Q3	$450K	Buy	3,674 +1,435	+64%	+$191K	0.01%	814
2019 Q2	$278K	Sell	2,239 -904	-29%	-$115K	0.01%	1022
2019 Q1	$415K	Buy	+3,143	New	+$424K	0.01%	833

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dupont Capital Management's ONC Position: Q2 2021 in Review

Dupont Capital Management sold out of BeOne Medicines Ltd (ONC) in Q2 2021, closing a stake of 1,442 shares — an estimated $502K sold.

Dupont Capital Management first reported a position in ONC in Q1 2019 and held it in 9 quarters. The position peaked at $1.18M in Q3 2020. 266 funds tracked by Wall St. Rank hold ONC as of Q2 2021.

Dupont Capital Management reported no remaining BeOne Medicines Ltd position as of Q2 2021 after selling out during the quarter.
Dupont Capital Management sold 1,442 BeOne Medicines Ltd shares in Q2 2021, an estimated $502K.
Dupont Capital Management first reported a position in BeOne Medicines Ltd in Q1 2019 and held it in 9 quarters.
Dupont Capital Management's BeOne Medicines Ltd position peaked at $1.18M in Q3 2020.
266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.